Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 11

1.

The incidence of cytomegalovirus (CMV) antigenemia and CMV disease is reduced by highly active antiretroviral therapy.

Varani S, Spezzacatena P, Manfredi R, Chiodo F, Mastroianni A, Ballarini P, Boschini A, Lazzarotto T, Landini MP.

Eur J Epidemiol. 2000 May;16(5):433-7.

PMID:
10997830
2.

Maternal IgG avidity and IgM detected by blot as diagnostic tools to identify pregnant women at risk of transmitting cytomegalovirus.

Lazzarotto T, Varani S, Spezzacatena P, Gabrielli L, Pradelli P, Guerra B, Landini MP.

Viral Immunol. 2000;13(1):137-41.

PMID:
10733175
3.

New advances in the diagnosis of congenital cytomegalovirus infection.

Lazzarotto T, Varani S, Gabrielli L, Spezzacatena P, Landini MP.

Intervirology. 1999;42(5-6):390-7. Review.

PMID:
10702722
4.

Cytomegalovirus infection in pregnancy: a still complicated diagnostic problem.

Lazzarotto T, Spezzacatena P, Pradelli P, Abate DA, Gabrielli L, Varani S, Landini MP.

Intervirology. 1998;41(4-5):149-57. Review.

PMID:
10213889
5.

Anticytomegalovirus (anti-CMV) immunoglobulin G avidity in identification of pregnant women at risk of transmitting congenital CMV infection.

Lazzarotto T, Spezzacatena P, Varani S, Gabrielli L, Pradelli P, Guerra B, Landini MP.

Clin Diagn Lab Immunol. 1999 Jan;6(1):127-9.

6.

Prenatal diagnosis of congenital cytomegalovirus infection.

Lazzarotto T, Guerra B, Spezzacatena P, Varani S, Gabrielli L, Pradelli P, Rumpianesi F, Banzi C, Bovicelli L, Landini MP.

J Clin Microbiol. 1998 Dec;36(12):3540-4.

7.

Delayed acquisition of high-avidity anti-cytomegalovirus antibody is correlated with prolonged antigenemia in solid organ transplant recipients.

Lazzarotto T, Varani S, Spezzacatena P, Pradelli P, Potena L, Lombardi A, Ghisetti V, Gabrielli L, Abate DA, Magelli C, Landini MP.

J Infect Dis. 1998 Oct;178(4):1145-9.

PMID:
9806047
8.

Development of a new cytomegalovirus (CMV) immunoglobulin M (IgM) immunoblot for detection of CMV-specific IgM.

Lazzarotto T, Ripalti A, Bergamini G, Battista MC, Spezzacatena P, Campanini F, Pradelli P, Varani S, Gabrielli L, Maine GT, Landini MP.

J Clin Microbiol. 1998 Nov;36(11):3337-41.

9.

Quantitative cytomegalovirus (CMV) antigenaemia during antiviral treatment of AIDS-related CMV disease.

Manfredi R, Lazzarotto T, Spezzacatena P, Dal Monte P, Mastroianni A, Coronado OV, Chiodo F.

J Antimicrob Chemother. 1997 Aug;40(2):299-302.

PMID:
9302001
10.

Avidity of immunoglobulin G directed against human cytomegalovirus during primary and secondary infections in immunocompetent and immunocompromised subjects.

Lazzarotto T, Spezzacatena P, Pradelli P, Abate DA, Varani S, Landini MP.

Clin Diagn Lab Immunol. 1997 Jul;4(4):469-73.

11.

A quantitative test (HCMV-hybrid-capture(TM)) to detect human cytomegalovirus DNA in the blood of immunocompromised patients compared with antigenemia and polymerase chain reaction.

Lazzarotto T, Campisi T, Dal Monte P, Galli S, Spezzacatena P, Guglielmi P, Landini MP.

New Microbiol. 1996 Jul;19(3):193-201.

PMID:
8841034

Supplemental Content

Loading ...
Support Center